CDC: 1 in 3 teen girls got cervical cancer vaccine

Sep 17, 2009 By MIKE STOBBE , AP Medical Writer

(AP) -- A new government report shows one in three teenage girls have rolled up their sleeves for a relatively new vaccine against cervical cancer, but vaccination rates vary dramatically between states.

The highest rates were in Rhode Island and New Hampshire, where more than half of girls ages 13 through 17 got at least one dose of three-shot vaccination. The lowest rates were in Mississippi, Georgia and South Carolina.

The federal report is the first to give state-by-state rates for the Gardasil vaccine that targets the sexually transmitted . The report was released Thursday by the .

---

On the Net:

CDC report: http://www.cdc.gov/mmwr

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Analgesics prescribed more heavily to women than to men, study finds

add to favorites email to friend print save as pdf

Related Stories

N.H. finds voluntary vaccination works

May 13, 2007

New Hampshire says it has a winning formula for getting teenage girls vaccinated against a virus linked to cervical cancer -- make the shot voluntary.

CDC, states: US swine flu cases jump to 68

Apr 28, 2009

(AP) -- The number of confirmed swine flu cases in the United States has jumped to 64, federal officials said Tuesday, and states reported at least four more.

Recommended for you

FDA has safety concerns on Merck insomnia drug

May 20, 2013

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

US adviser on board of firm that sold anthrax drug

May 20, 2013

(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...

First influenza vaccine brought to clinical testing

May 17, 2013

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

User comments : 0

More news stories

Glaucoma drug can cause droopy eyelids

Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...